Forum.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 49, doi. 10.1007/BF03256892
- Publication type:
- Article
Works matching IS 11782595 AND DT 2012 AND VI 26 AND IP 1
Results: 9
1
2
Major Pharmaceutical Conferences and Courses.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 73, doi. 10.1007/BF03256894
- Publication type:
- Article
3
Journal Watch.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 63, doi. 10.1007/BF03256893
- Publication type:
- Article
4
Phase III ATENA Trial of Exemestane Discontinued.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 45, doi. 10.1007/BF03256891
- By:
- Publication type:
- Article
5
Drugs in Clinical Development for Type 2 Diabetes Mellitus.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 27, doi. 10.1007/BF03256890
- Publication type:
- Article
6
Pharmacovigilance in Qatar Hospitals.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 23, doi. 10.1007/BF03256889
- By:
- Publication type:
- Article
7
Methodological Issues in the Design of Paediatric Pharmacokinetic Studies.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 13, doi. 10.1007/BF03256888
- By:
- Publication type:
- Article
8
Comparative Effectiveness Research in the Regulatory Setting.
- Published in:
- Pharmaceutical Medicine, 2012, v. 26, n. 1, p. 5, doi. 10.1007/BF03256887
- By:
- Publication type:
- Article
9
The Pharmaceutical Medicine Year that Was, 2011.
- Published in:
- 2012
- By:
- Publication type:
- Opinion